PDGF is shown to promote immune cell recruitment through the modulation of the PI3K/Akt and MAPK/ERK pathway to stimulate endometrial cancer cell proliferation, which we have already identified to be a downstream effect of the GnRH-(1–5) signaling pathway (45, 57, 76). The gene discussed is AKT1; the disease is endometrial cancer.